Chair, Cancer Center Directors

Howard H. Bailey, MD is the director of the University of Wisconsin Carbone Cancer Center and a professor of Medicine at the UW School of Medicine and Public Health. Dr. Bailey’s clinical expertise is in sarcomas and gynecologic malignancies and his research focus is in anti-cancer drug development, especially chemoprevention, and research network development. Dr. Bailey also leads the UWCCC Chemoprevention Scientific Program and Chemoprevention Disease Orientated Work Group. He was appointed to the national committee which reviews all NCI-designated Cancer Centers in 2011.


Chair, Big Ten Cancer Research Consortium Foundation

George J. Weiner, MD is director of the Holden Comprehensive Cancer Center at the University of Iowa. He also serves as C.E. Block Chair of Cancer Research, professor of internal medicine, and a faculty member in the interdisciplinary graduate program in immunology at the University of Iowa. He is director of the University of Iowa / Mayo Clinic Specialized Program of Research Excellence (SPORE) in lymphoma, and president of the Iowa Cancer Consortium.


Chief Scientific Officer

Monika Joshi, MD, MRCP is an associate professor in the Division of Hematology-Oncology in Department of Medicine at the Penn State Cancer Institute (PSCI). She serves as disease team co-leader for the genitourinary diseases group at the PSCI and as medical director for the PSCI Clinical Trials Office. Her clinical and research interests lie primarily in the field of genitourinary tumors, particularly in the field of immunotherapy and targeted therapy. She has an interest in developing clinical trials with novel immunotherapeutic combinations and identifying predictive and prognostic biomarkers. Dr. Joshi has been active in the Big Ten CRC since the consortium’s founding in 2013. In addition to leading multiple Big Ten CRC studies, she he served on the Big Ten CRC Steering Committee and as a co-chair the Genitourinary Clinical Trial Working Group.


Administrative Officer

Abigail Proctor is the administrative point of contact for the Big Ten Cancer Research Consortium. She facilitates calls and in-person meetings for the Big Ten CRC Clinical Trial Working Groups, Cancer Center Directors, and Steering Committee. She actively engages with investigators from Big Ten universities to encourage their participation in Big Ten CRC research.
 


Steering Committee

The Big Ten CRC Steering Committee is composed of one researcher from each member institution. The Steering Committee meets on a regular basis to review activities of the consortium and decide matters of policy. The Steering Committee determines the criteria for approving concepts for development with the Big Ten CRC.